基于网络药理学和分子对接,探索Polygonatum sibiricum对阿尔茨海默病的潜在机制:一项观察性研究

相关实验视频

Updated: May 27, 2025

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

442

Liangliang Luo¹, Yao Pan^1,2, Fang Chen^1,2

¹School of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, China.

Medicine

|February 19, 2025

概括

多胞胎通过向多个途径和基因,显示出对阿尔茨海默病 (AD) 治疗的潜力. 这项研究揭示了它的多组件,多目标机制,为AD提供了一个新的治疗策略.

科学领域:

药理学药理学是指药理学的学科.
计算生物学计算生物学
神经科学是一个神经科学.

背景情况:

阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,治疗选择有限.
目前尚缺少关于多角对阿尔茨海默病的治疗机制的系统研究.

研究的目的:

通过网络药理学和分子对接,阐明多角体对抗阿尔茨海默病的机制.
为了确定参与Polygonatum抗老年衰老作用的活性成分,点和途径.

主要方法:

网络药理学用于识别Polygonatum的活性成分和标.
生物信息学数据库 (如GeneCards,Disgenet) 用于AD目标.
蛋白质与蛋白质相互作用网络建设 (STRING).
基因本体学 (GO) 和基因和基因组的京都百科全书 (KEGG) 路径丰富分析.
分子对接 (AutoDock4) 用于验证.

主要成果:

对抗AD的Polygonatum确定了10种活性成分和108种共同目标.
确定了29个核心基因,包括AKT1和STAT3.
关键的途径包括癌症,神经退行以及PI3K-Akt信号传递的途径.
分子对接证实了10个活性成分和6个核心目标之间强烈的结合亲和力.

结论:

多角体通过多组件,多目标和多途径机制表现出对抗阿尔茨海默病的潜力.
鉴定的途径和目标为AD提供了一个新的治疗策略.
需要进一步的研究来验证这些发现在临床前和临床环境中.

相关概念视频

01:22

Alzheimer's Disease: Treatment

150

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

150

01:26

Alzheimer's Disease: Overview

429

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

429

01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

2.1K

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...